EPC Stock Analysis: Edgewell Personal Care | NYSE
Household & Personal Products | NYSE, USA | Market Cap: 1.331m USD | 12M Return: 25.8% | US28035Q1022 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.8M
EPS Trend: -66.8%
Qual. Beats: 0
Rev. Trend: -86.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Edgewell Personal Care Company (NYSE: EPC) is a U.S.-based manufacturer and marketer of personal care products sold worldwide, organized into three reportable segments: Wet Shave, Sun and Skin Care, and Feminine Care. Founded in 1772 and headquartered in Shelton, Connecticut, the company was formerly known as Energizer Holdings, Inc. before rebranding in June 2015. It distributes products through a combination of a direct sales force, exclusive and non-exclusive distributors, and wholesalers.
The Wet Shave segment is the companys largest historical business, offering razor systems, disposable razors, and shave preparation products under the Schick, Wilkinson Sword, Edge, Skintimate, Billie, and Skintimate brands, along with private label offerings. The Sun and Skin Care segment includes sun care products under the Banana Boat and Hawaiian Tropic brands, antibacterial wipes under Wet Ones, and mens grooming and skin care products under Bulldog, Jack Black, and Cremo. The Feminine Care segment markets tampons under the Playtex and o.b. brands, along with pads and liners under the Stayfree and Carefree labels.
As a small-cap stock in the Consumer Staples sector (GICS Sub-Industry: Personal Care Products), Edgewell operates in a category where brand equity, retail shelf placement, and consumer loyalty are central to the business model, and demand tends to be relatively stable through economic cycles. The company holds a portfolio of established heritage brands that compete against larger packaged goods companies, with its distribution model reaching both mass-market retailers and specialty channels globally.
- Wet Shave segment performance hinges on Schick and Billie brand momentum
- Sun Care revenue fluctuates with summer season and travel demand
- Private label competition and FX headwinds pressure margins
| Net Income: -93.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.36 > 1.0 |
| NWC/Revenue: 24.80% < 20% (prev 19.84%; Δ 4.96% < -1%) |
| CFO/TA 0.03 > 3% & CFO 121.2m > Net Income -93.2m |
| Net Debt (898.4m) to EBITDA (55.0m): 16.33 < 3 |
| Current Ratio: 1.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.6m) vs 12m ago -2.92% < -2% |
| Gross Margin: 40.87% > 18% (prev 42.16%; Δ -1.29% > 0.5%) |
| Asset Turnover: 55.93% > 50% (prev 58.10%; Δ -2.17% > 0%) |
| Interest Coverage Ratio: -0.22 > 6 (EBIT TTM -14.9m / Interest Expense TTM 68.7m) |
| A: 0.14 (Total Current Assets 1.11b - Total Current Liabilities 603.6m) / Total Assets 3.54b |
| B: 0.28 (Retained Earnings 1.00b / Total Assets 3.54b) |
| C: -0.00 (EBIT TTM -14.9m / Avg Total Assets 3.66b) |
| D: 0.70 (Book Value of Equity 1.46b / Total Liabilities 2.08b) |
| Altman-Z'' = 2.58 = A |
| DSRI: 0.93 (Receivables 188.7m/218.9m, Revenue 2.05b/2.20b) |
| GMI: 1.03 (GM 42.16% / 40.87%) |
| AQI: 0.94 (AQ_t 0.60 / AQ_t-1 0.64) |
| SGI: 0.93 (Revenue 2.05b / 2.20b) |
| TATA: -0.06 (NI -93.2m - CFO 121.2m) / TA 3.54b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of September 14, 2026, the stock is trading at USD 26.93 with a total of 421,590 shares traded. Over the past week, the price has changed by -4.99%, over one month by -5.36%, over three months by +25.07% and over the past year by +25.82%.
Current recommended Stop Loss: 24.10 (which is 10.5% or 2.5 ATR below the current price).
Edgewell Personal Care has received a consensus analysts rating of 3.78. Therefore, it is recommended to hold EPC.
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 32.2 | 19.5% |
P/E Forward = 13.9082
P/S = 0.593
P/B = 0.8997
P/EG = 2.8727
Revenue TTM = 2.05b USD
EBIT TTM = -14.9m USD
EBITDA TTM = 55.0m USD
Long Term Debt = 1.25b USD (from longTermDebt, last quarter)
Short Term Debt = 34.2m USD (from shortTermDebt, last quarter)
Debt = 1.30b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.3m
Net Debt = 898.4m USD (calculated: Debt 1.30b - CCE 397.1m)
Enterprise Value = 2.23b USD (1.33b + Debt 1.30b - CCE 397.1m)
Interest Coverage Ratio = -0.22 (Ebit TTM -14.9m / Interest Expense TTM 68.7m)
EV/FCF = 42.54x (Enterprise Value 2.23b / FCF TTM 52.4m)
FCF Yield = 2.35% (FCF TTM 52.4m / Enterprise Value 2.23b)
FCF Margin = 2.56% (FCF TTM 52.4m / Revenue TTM 2.05b)
Net Margin = -4.55% (Net Income TTM -93.2m / Revenue TTM 2.05b)
Gross Margin = 40.87% ((Revenue TTM 2.05b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 42.54% (prev 43.43%)
Tobins Q-Ratio = 0.63 (Enterprise Value 2.23b / Total Assets 3.54b)
Interest Expense / Debt = 5.30% (Interest Expense 68.7m / Debt 1.30b)
Taxrate = 31.67% (5.70m / 18.0m)
NOPAT = -10.2m (EBIT -14.9m * (1 - 31.67%)) [loss with tax shield]
Current Ratio = 1.84 (Total Current Assets 1.11b / Total Current Liabilities 603.6m)
Debt / Equity = 0.89 (Debt 1.30b / totalStockholderEquity, last quarter 1.46b)
Debt / EBITDA = 16.33 (Net Debt 898.4m / EBITDA 55.0m)
Debt / FCF = 17.15 (Net Debt 898.4m / FCF TTM 52.4m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.54% (Net Income -93.2m / Total Assets 3.54b)
RoE = -6.27% (Net Income TTM -93.2m / Total Stockholder Equity 1.49b)
RoCE = -0.55% (EBIT -14.9m / Capital Employed (Equity 1.49b + L.T.Debt 1.25b))
RoIC = -0.36% (negative operating profit) (NOPAT -10.2m / Invested Capital 2.86b)
WACC = 5.14% (E(1.33b)/V(2.63b) * Re(6.61%) + D(1.30b)/V(2.63b) * Rd(5.30%) * (1-Tc(0.32)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.29 | Cagr: -3.25%
[DCF] Terminal Value 77.97% ; FCFF base≈48.5m ; Y1≈55.6m ; Y5≈81.9m
[DCF] Fair Price = 7.23 (EV 1.23b - Net Debt 898.4m = Equity 333.4m / Shares 46.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -66.75 | EPS CAGR: -11.02% | SUE: 0.68 | # QB: 0
Revenue Correlation: -86.09 | Revenue CAGR: -3.06% | SUE: -0.30 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.01 | Chg30d=+113.66% | Revisions=+57% | Analysts=6
EPS current Year (2026-09-30): EPS=1.93 | Chg30d=+1.91% | Revisions=+30% | GrowthEPS=-23.6% | GrowthRev=-10.4%
EPS next Year (2027-09-30): EPS=2.01 | Chg30d=-2.32% | Revisions=-50% | GrowthEPS=+4.5% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: +10% (up=10, down=8)